Quantitative Analysis of Transcranial and Intraparenchymal Light Penetration in Human Cadaver Brain Tissue

Clark E. Tedford,¹ Scott DeLapp,¹ Steven Jacques,² and Juanita Anders³ ¹LumiThera, Inc., Poulsbo, Washington 98370 ²Oregon Health and Science University, Portland, Oregon ³Department of Anatomy, Physiology and Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 Background and Objective: Photobiomodulation (PBM) also known as low-level light therapy has been used successfully for the… Continue reading →

Retired Congressman Norman Dicks Joins LumiThera’s Advisory Team

SEATTLE, May 6, 2015 /PRNewswire/ — LumiThera Inc., a medical device company focused on the development of non-invasive photobiomodulation (PBM) treatment for ocular disorders and disease, today announced Retired Congressman Norman Dicks has agreed to join LumiThera’s Advisory Board to assist in the company’s mission to treat vision impairment. Norman DeValois “Norm” Dicks was the… Continue reading →

Absorption of Monochromatic and Narrow Band Radiation in the Visible and Near IR by Both Mitochondrial and Non-Mitochondrial Photoacceptors Results in Photobiomodulation

Passarella S, Karu T. Institute of Laser and Information Technologies of the Russian Academy of Sciences, 142190 Troitsk, Moscow Region, Russian Federation. Abstract In addition to the major functions performed by in the cell, mitochondria play a major role in cell-light interaction. Accordingly it is generally accepted that mitochondria are crucial in cell photobiomodulation; however… Continue reading →

Retired Major General Gale Pollock Joins LumiThera’s Scientific Advisory Board

SEATTLE, June 9, 2014 /PRNewswire/ – LumiThera Inc., a medical device company focused on the development of non-invasive light emitting diode (LED) treatments for ocular disorders and disease, today announced Ret. Major General Gale Pollock has joined their Scientific Advisory Board. The first woman to serve as Acting Surgeon General of the United States Army… Continue reading →

Video Introduction

United Nations Headquarters (New York) presentation to the Global Health Impact Forum, 6th May 2014 by co founder James Carroll This 15 minute video starts with an overview of Photobiomodulation and low level light therapy as it relates to his company THOR Photomedicine. Later in the presentation James introduces Lumithera and our treatment for Age related… Continue reading →

Treatment with 670 nm Light Upregulates Cytochrome C Oxidase Expression and Reduces Inflammation in an Age-Related Macular Degeneration Model

Begum R, Powner MB, Hudson N, Hogg C, Jeffery G Institute of Ophthalmology, University College London, London, United Kingdom. Abstract Inflammation is an umbrella feature of ageing. It is present in the aged retina and many retinal diseases including age-related macular degeneration (AMD). In ageing and in AMD mitochondrial function declines. In normal ageing this… Continue reading →

Recharging Mitochondrial Batteries in Old Eyes. Near Infra-Red Increases ATP

Gkotsi D, Begum R, Salt T, Lascaratos G, Hogg C, Chau KY, Schapira AH, Jeffery G. Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK. Moorfields Eye Hospital, UK. Institute of Neurology, University College London, UK. Institute of Ophthalmology, University College London, 11-43 Bath Street, London EC1V 9EL, UK. Abstract Progressive… Continue reading →

Low-Level Laser Therapy Improves Vision in a Patient with Retinitis Pigmentosa

Ivandic BT, Ivandic T. University of Heidelberg , Otto Meyerhof Centre, Heidelberg, Germany OBJECTIVE: This case report describes the effects of low-level laser therapy (LLLT) in a single patient with retinitis pigmentosa (RP). Background data: RP is a heritable disorder of the retina, which eventually leads to blindness. No therapy is currently available. METHODS: LLLT… Continue reading →

Photobiomodulation in the Treatment of Patients with Non-Center-Involving Diabetic Macular Oedema

Tang J, Herda AA, Kern TS. Department of Ophthalmology, University of Kansas Medical Center, Prairie Village, Kansas, USA PURPOSE: Far-red/near-infrared phototherapy or photobiomodulation (PBM) has recently been reported to be an effective and non-invasive treatment method to inhibit lesions of diabetic retinopathy (DR) in animals. This study investigated the safety and efficacy of PBM in… Continue reading →

670nm Photobiomodulation as a Novel Protection Against Retinopathy of Prematurity: Evidence from Oxygen Induced Retinopathy Models

Natoli R, Valter K, Barbosa M, Dahlstrom J, Rutar M, Kent A, Provis J The John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory, Australia ; ARC Centre of Excellence in Vision Science, Australian National University, Canberra, Australian Capital Territory, Australia ; ANU Medical School, Australian National University, Canberra, Australian Capital… Continue reading →